Janus Henderson Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.54M Buy
164,749
+125,521
+320% +$3.46M ﹤0.01% 934
2025
Q1
$1.22M Buy
39,228
+1,545
+4% +$48.1K ﹤0.01% 1523
2024
Q4
$1.57M Sell
37,683
-2,924
-7% -$122K ﹤0.01% 1441
2024
Q3
$2.71M Buy
40,607
+3,700
+10% +$247K ﹤0.01% 1157
2024
Q2
$4.38M Sell
36,907
-8,519
-19% -$1.01M ﹤0.01% 897
2024
Q1
$4.84M Sell
45,426
-107
-0.2% -$11.4K ﹤0.01% 891
2023
Q4
$4.53M Sell
45,533
-386,480
-89% -$38.4M ﹤0.01% 851
2023
Q3
$44.6M Buy
432,013
+40,295
+10% +$4.16M 0.03% 384
2023
Q2
$47.6M Buy
391,718
+338,671
+638% +$41.2M 0.03% 398
2023
Q1
$8.15M Buy
53,047
+9,252
+21% +$1.42M 0.01% 745
2022
Q4
$7.86M Sell
43,795
-466,893
-91% -$83.8M 0.01% 770
2022
Q3
$60.4M Buy
510,688
+232,552
+84% +$27.5M 0.02% 473
2022
Q2
$39.7M Sell
278,136
-400,978
-59% -$57.3M 0.03% 428
2022
Q1
$117M Sell
679,114
-159,081
-19% -$27.4M 0.06% 292
2021
Q4
$213M Buy
838,195
+167,352
+25% +$42.5M 0.09% 223
2021
Q3
$258M Sell
670,843
-505,371
-43% -$195M 0.11% 194
2021
Q2
$276M Buy
1,176,214
+649,446
+123% +$153M 0.12% 188
2021
Q1
$69M Buy
526,768
+377,476
+253% +$49.4M 0.03% 463
2020
Q4
$15.6M Buy
149,292
+45,392
+44% +$4.74M 0.01% 793
2020
Q3
$7.35M Sell
103,900
-753,857
-88% -$53.3M ﹤0.01% 868
2020
Q2
$55.1M Buy
857,757
+776,564
+956% +$49.9M 0.03% 461
2020
Q1
$2.43M Buy
+81,193
New +$2.43M ﹤0.01% 978